Simultaneous mapping of blood volume and endothelial permeability surface area product in gliomas using iterative analysis of first-pass dynamic contrast enhanced MRI data

British Journal of Radiology

Volumn 76, Issue 901, 2003, Pages 39-50

  Li, Kaloh L ^a,c   Zhu, X P ^a   Checkley, D R ^b   Tessier, J J L ^a   Hillier, V F ^b   Waterton, J C ^b   Jackson, A ^a  

^a UNIVERSITY OF MANCHESTER   (United Kingdom)

^b ASTRAZENECA   (United Kingdom)

^c UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CONTRAST MEDIUM;

ARTICLE; BLOOD VESSEL PERMEABILITY; BLOOD VOLUME; BRAIN BLOOD FLOW; CLINICAL ARTICLE; CONTAMINATION; CONTRAST ENHANCEMENT; CONTROLLED STUDY; CORRELATION ANALYSIS; EXTRAVASCULAR SPACE; GLIOMA; HEMODYNAMIC MONITORING; HEMODYNAMIC PARAMETERS; HUMAN; IMAGING SYSTEM; METHODOLOGY; NUCLEAR MAGNETIC RESONANCE IMAGING; OUTCOMES RESEARCH; REPRODUCIBILITY; TUMOR VASCULARIZATION;

AGED; BLOOD VOLUME; BRAIN NEOPLASMS; CONTRAST MEDIA; ENDOTHELIUM, VASCULAR; GLIOMA; HUMANS; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; MODELS, CARDIOVASCULAR; REPRODUCIBILITY OF RESULTS;

EID: 0037280345     PISSN: 00071285     EISSN: None     Source Type: Journal    
DOI: 10.1259/bjr/31662734     Document Type: Article

References (37)

1. Axel L. Cerebral blood flow determination by rapid-sequence computed tomography. Radiology 1980;137:679.
2. Folkman J. What is the evidence that tumors are angiogenesis dependent? J Natl Cancer Inst 1990;82:4-6.
3. Gasparini G. Prognostic and predictive value of intra-tumoural microvessel density in human solid tumours. In: Bicknell R, Lewis C, Ferrara N, editors. Tumour Angiogenesis. Oxford, UK: Oxford University Press; 1997:29-44.
4. Aronen HJ, Glass J, Pardo FS, Belliveau JW, Gruber ML, Buchbinder BR, et al. Echo-planar MR cerebral blood volume mapping of gliomas. Clinical utility. Acta Radiol 1995;36:520-8.
5. Bruening R, Kwong KK, Vevea MJ, Hochberg FH, Cher L, Harsh GR, et al. Echo-planar MR determination of relative cerebral blood volume in human brain tumors: T1 versus T2 weighting. AJNR 1996;17:831-40.
6. Leung DW, Cachianes G, Kuang WJ, Goeddel DV, Ferrara N. Vascular endothelial growth factor is a secreted angiogenic mitogen. Science 1989;246:1306-9.
7. Brasch R, Pham C, Shames D, Roberts T, Van Dijke K, Van Bruggen N, et al. Assessing tumor angiogenesis using macromolecular MR imaging contrast media. J Magn Reson Imaging 1997;7:68-74.
8. Brix G, Bahner ML, Hoffmann U, Horvath A, Schreiber W. Regional blood flow, capillary permeability, and compartmental volumes: Measurement with dynamic CT-initial experience. Radiology 1999;210:269-76.
9. Tofts PS, Kermode AG. Measurement of the blood-brain barrier permeability and leakage space using dynamic MR imaging. 1. Fundamental concepts. Magn Reson Med 1991;17:357-67.
10. Larsson HB, Stubgaard N, Frederiksen JL, Jensen M, Henriksen O, Paulson OB. Quantitation of blood-brain barrier defect by magnetic resonance imaging and gadolinium-DTPA in patients with multiple sclerosis and brain tumors. Magn Reson Med 1990;16:117-31.
11. Brix G, Semmler W, Port R, Schad LR, Layer G, Lorenz WJ. Pharmacokinetic parameters in CNS Gd-DTPA enhanced MR imaging. J Comput Assist Tomogr 1991;15:621-8.
12. Den Boer JA, Hoenderop RK, Smink J, Dornseiffen G, Koch PW, Mulder JH, et al. Pharmacokinetic analysis of Gd-DTPA enhancement in dynamic three-dimensional MRI of breast lesions. J Magn Reson Imaging 1997;7:702-15.
13. Henderson E, Sykes J, Drost D, Weinmann HJ, Rutt BK, Lee TY. Simultaneous MRI measurement of blood flow, blood volume and capillary permeability in mammary tumours using two different contrast agents. J Magn Reson Imaging 2000;12:991-1003.
14. Parker GJ, Suckling J, Tanner SF, Padhani AR, Revell PB, Husband JE, et al. Probing tumor microvascularity by measurement, analysis and display of contrast agent uptake kinetics. J Magn Reson Imaging 1997;7:564-74.
15. Weisskoff RM, Boxerman JL, Sorensen AG, Kulke SM, Campbell TA, Rosen BR. Simultaneous blood volume and permeability mapping using Gd-based contrast injection. In: Proceedings of the 2nd Scientific Meeting of the International Society of Magnetic Resonance in Medicine; 1994; San Francisco, CA. Berkley, CA: ISMRM, 1994. 297.
16. Larsson HB, Fritz-Hansen T, Rostrup E, Sondergaard L, Ring P, Henriksen O. Myocardial perfusion modeling using MRI. Magn Reson Med 1996;35:716-26.
17. Ostergaard L, Hochberg FH, Rabinov JD, Sorensen AG, Lev M, Kim L, et al. Early changes measured by magnetic resonance imaging in cerebral blood flow, blood volume, and blood-brain barrier permeability following dexamethasone treatment in patients with brain tumors. J Neurosurg 1999;90:300-5.
18. Li KL, Zhu XP, Waterton J, Jackson A. Improved 3D quantitative mapping of blood volume and endothelial permeability in brain tumors. J Magn Reson Imaging 2000;12:347-57.
19. Kety SS, Schmidt CF. The nitrous oxide method for quantitative determination of cerebral blood flow in man: Theory, procedure and normal values. J Clin Invest 1948;6:476-84.
20. Kassner A, Annesley DJ, Zhu XP, Li KL, Kamaly-Asl ID, Watson Y, et al. Abnormalities of the contrast re-circulation phase in cerebral tumors demonstrated using dynamic susceptibility contrast-enhanced imaging: A possible marker of vascular tortuosity. J Magn Reson Imaging 2000;11:103-13.
21. Tofts PS, Brix G, Buckley DL, Evelhoch JL, Henderson E, Knopp MV, et al. Estimating kinetic parameters from dynamic contrast-enhanced T(1)-weighted MRI of a diffusable tracer: Standardized quantities and symbols. J Magn Reson Imaging 1999;10:223-32.
22. Tofts PS, Berkowitz BA. Rapid measurement of capillary permeability using the early part of the dynamic Gd-DTPA MRI enhancement curve. J Magn Reson B 1993;102:129-36.
23. Zhu XP, Li KL, Kamaly-Asl ID, Checkley DR, Tessier JJ, Waterton JC, et al. Quantification of endothelial permeability, leakage space, and blood volume in brain tumors using combined T1 and T2* contrast-enhanced dynamic MR imaging. J Magn Reson Imaging 2000;11:575-85.
24. Rosen BR, Belliveau JW, Vevea JM, Brady TJ. Perfusion imaging with NMR contrast agents. Magn Reson Med 1990;14:249-65.
25. Edmister WB, Weisskoff RM. Optimal time resolution for dynamic breast imaging. In: Proceedings of the 6th Scientific Meeting of the International Society of Magnetic Resonance in Medicine; 1998 Sydney, Australia. Berkley, CA: ISMRM, 1998. 228.
26. Nie NH, Hull CH. SPSS Update 7-9. New York, NY, McGraw-Hill Book Company, 1981:234.
27. Larson KB, Perman WH, Perlmutter JS, Gado MH, Ollinger JM, Zierler K. Tracer-kinetic analysis for measuring regional cerebral blood flow by dynamic nuclear magnetic resonance imaging. J Theor Biol 1994;170:1-14.
28. Donahue KM, Weisskoff RM, Parmelee DJ, Callahan RJ, Wilkinson RA, Mandeville JB, et al. Dynamic Gd-DTPA enhanced MRI measurement of tissue cell volume fraction. Magn Reson Med 1995;34:423-32.
29. Hacklander T, Hofer M, Reichenbach, Rascher K, Furst G, Modder U. Cerebral blood volume maps with dynamic contrast-enhanced T1-weighted FLASH imaging: Normal values and preliminary clinical results. J Comput Assist Tomogr 1996;20:532-9.
30. Donahue KM, Weisskoff RM, Chesler DA, Kwong KK, Bogdanov AA, Mandeville JB, et al. Improving MR quantification of regional blood volume with intravascular T1 contrast agents: Accuracy, precision, and water exchange. Magn Reson Med 1996;36:858-67.
31. Buckley DL. Uncertainty in the analysis of tracer kinetics using dynamic contrast-enhanced T1-weighted MRI. Magn Reson Med 2002;47:601-6.
32. Evelhoch JL. Key factors in the acquisition of contrast kinetic data for oncology. J Magn Reson Imaging 1999;10:254-9.
33. Gowland P, Mansfield P, Bullock P, Stehling M, Worthington B, Firth J. Dynamic studies of gadolinium uptake in brain tumors using inversion-recovery echo-planar imaging. Magn Reson Med 1992;26:241-58.
34. Larsson HB, Stubgaard M, Sondergaard L, Henriksen O. In vivo quantification of the unidirectional influx constant for Gd-DTPA diffusion across the myocardial capillaries with MR imaging. J Magn Reson Imaging 1994;4:433-40.
35. Henderson E, Rutt BK, Lee TY. Temporal sampling requirements for the tracer kinetics modeling of breast disease. Magn Reson Imaging 1998;16:1057-73.
36. Donahue KM, Pathak A, Rand S, Prost R, Krouwer H. Utility of acquiring vascular blood volume, permeability and morphology information from dynamic susceptibility contrast agent studies in patients with brain tumors. In: Proceedings of the 7th Scientific Meeting of the International Society of Magnetic Resonance in Medicine; 1999; Philadelphia, PA. Berkley, CA: ISMRM, 1999:149.
37. Mayr NA, Hawighorst H, Yuh WT, Essig M, Magnotta VA, Knopp MV. MR microcirculation assessment in cervical cancer: Correlations with histomorphological tumor markers and clinical outcome. J Magn Reson Imaging 1999;10:267-76.